Unbalanced risk-benefit analysis of ADHD drugs – Authors’ reply.

Icon for Elsevier Science Related Articles

Unbalanced risk-benefit analysis of ADHD drugs – Authors’ reply.

Lancet Psychiatry. 2018 11;5(11):871-873

Authors: Cipriani A, Adamo N, Giovane CD, Coghill D, Banaschewski T, Hollis C, Zuddas A, Simonoff E, Cortese S

PMID: 30401441 [PubMed – indexed for MEDLINE]

via https://www.ncbi.nlm.nih.gov/pubmed/30401441?dopt=Abstract